https://www.zonebourse.com/cours/action/BIOMEA-FUSION-INC-121456063/actualite/Biomea-Fusion-Inc-annonce-que-le-premier-patient-a-recu-la-dose-de-BMF-500-un-inhibiteur-covalen-45083527/?utm_source=telegram&utm_medium=social&utm_campaign=share